Acute aldosterone infusion enhances thrombosis development in normotensive rats.
Stankiewicz
Adrian
A
Gromotowicz
Anna
A
Szemraj
Janusz
J
Wojewódzka-Zelezniakowicz
Marzena
M
Skrzypkowski
Przemyslaw
P
Chabielska
Ewa
E
D000450:Aldosterone / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism*; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D025901:Carboxypeptidase B2 / Q000097:blood; D004195:Disease Models, Animal; D000077545:Eplerenone; D007262:Infusions, Intravenous; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D051381:Rats; D017208:Rats, Wistar; D018161:Receptors, Mineralocorticoid / Q000378:metabolism*; D013148:Spironolactone / Q000031:analogs & derivatives / Q000494:pharmacology; D013925:Thromboplastin / Q000378:metabolism; D013927:Thrombosis / Q000097:blood / Q000139:chemically induced / Q000378:metabolism* / Q000503:physiopathology; D010959:Tissue Plasminogen Activator / Q000097:blood
D000451:Mineralocorticoid Receptor Antagonists; D017395:Plasminogen Activator Inhibitor 1; D018161:Receptors, Mineralocorticoid; D013148:Spironolactone; D000450:Aldosterone; D000077545:Eplerenone; D013925:Thromboplastin; D025901:Carboxypeptidase B2; D010959:Tissue Plasminogen Activator